Latest Morning Briefing Stories
While Stephen Hahn says the FDA is not in a position to “regulate the practice of medicine,” a group of researchers oppose doctors prescribing the anti-malarial drug for COVID.
As drugmakers race to develop a vaccine, exactly how those vaccines will be manufactured and delivered to Americans is also being planned. In other vaccine news: Johnson & Johnson moves to human trials of its vaccine. And a Moderna board member resigns.
Big Pharma executives ignore the president’s invitation to meet at the White House. Cerevel plans to go public. Meanwhile, medical charities are forced to cut back on galas and other charity events they use to raise money.
Whether Missouri should expand its Medicaid program will be put to voters next Tuesday. In other Medicaid news: Texas extends pandemic flexibility; telehealth users want permanent change; and many doctors support benefits for unemployed.
During a roundtable at the Red Cross headquarters, President Donald Trump and other public health officials called on coronavirus survivors to donate. “You’ve gotten through it, and I guess that means you have something very special there,” Trump said.
Public health experts warn that the positive trend could slip back if Americans aren’t vigilant. And states like Arizona, Florida and Mississippi continue to break records for confirmed new cases.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Also in the news today: Covered California; CARES Act funds in Georgia, SOC Telemed; and a major hospital apologizes for performing cosmetic genital surgeries on intersex infants.
Maryland’s governor toughens his mask mandate, even though Dr. Anthony Fauci says they are difficult to enforce.
A group called America’s Frontline Doctors captured national attention for their unproven claims in an online video seen by millions–despite being banned from some social media platforms for misinformation–about the efficacy of hydroxychloroquine and masks. Vice President Mike Pence met with several of the doctors on Tuesday.
An NPR investigation finds irregularities in the TeleTracking Technologies contract for a database previously managed by the CDC. In other Trump administration news, Modern Healthcare obtains partial text of White House drug pricing executive orders.
The United States blew past another tragic milestone, reporting 150,000 deaths due to the COVID-19 outbreak. New case counts and the death rate continue to climb to record or near-record levels — especially in Texas.
The drugmaker says it might reconsider plans to expand in the U.S. if the executive orders are implemented. Read about this and other pharmaceutical developments from the past week in KHN’s Prescription Drug Watch roundup.
A rural hospital chain goes bust while a big urban one reports higher profits. In other hospital industry news, the government won’t penalize hospitals that donate or sell unpaid bills to charities that pay off the debts.
Media outlets report on news about discrimination faced by two Black pediatricians, mothers who become activists and a Black community concerned about growing health risks.
It’s a crazy quilt of plans and rules as school districts try to get teaching back on track. The Trump administration is still pushing full in-person instruction. “The COVID-19 pandemic has stumped the brightest minds at universities,” says the Wall Street Journal.
The physician who expressed indifference to the veteran’s condition was a contract worker at Washington, D.C.’s VA Medical Center’s emergency room.
The new research of a potential blood test offers hope for Alzheimer’s research and treatment as the degenerative disease can now only be diagnosed through scans or spinal taps after memory has already faltered.
The results are encouraging, though the animal test does not guarantee that the developmental vaccine will work as well on humans.
Despite the imminent expiration of current aid, a quick path to another round of coronavirus stimulus gets tougher as a number of Republican senators object to several of the provisions in their party’s proposal.